Greenwich LifeSciences, Inc. (GLSI)
NASDAQ: GLSI · Real-Time Price · USD
17.10
-1.63 (-8.70%)
Aug 28, 2026, 12:23 PM EDT - Market open
Greenwich LifeSciences Market Cap
Greenwich LifeSciences has a market cap or net worth of $251 million as of August 28, 2026. Its market cap has increased by 57.80% in one year.
Market Cap
251.00M
Enterprise Value
242.12M
1-Year Change
57.80%
Ranking
Category
Stock Price
$17.10
ChartMarket Cap Chart
Since the IPO on September 25, 2020, Greenwich LifeSciences's market cap has increased from $68.69M to $251.00M, an increase of 265.42%. That is a compound annual growth rate of 24.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 251.00M | -13.77% |
| Dec 31, 2025 | 291.08M | 97.19% |
| Dec 31, 2024 | 147.61M | 9.21% |
| Dec 29, 2023 | 135.16M | -30.79% |
| Dec 30, 2022 | 195.29M | -38.84% |
| Dec 31, 2021 | 319.29M | -31.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 282.25M |
| Neumora Therapeutics | 281.84M |
| Camp4 Therapeutics | 279.25M |
| Invivyd | 276.69M |
| ALX Oncology Holdings | 276.55M |
| Entrada Therapeutics | 274.75M |
| Surrozen | 274.56M |
| Compugen | 271.86M |